Ischemic heart disease Board decisions

The Board granted service connection for arteriosclerotic heart disease and ventricular arrhythmias, finding that the evidence supports a link to the Veteran's military service.

The appeal is remanded for the Agency of Original Jurisdiction to ensure that a copy of the March 2022 SSOC is mailed to the correct address.

The Board remands the issue of entitlement to service connection for a heart disability, including bicuspid aortic valve disease, systolic murmur, coronary artery disease, and aortic stenosis, due to an incomplete medical opinion.

The Board granted service connection for a heart disability due to an undiagnosed illness and denied increased ratings for left and right knee patellofemoral pain syndrome.

The Board remands the appeal for further development, including obtaining the Veteran's complete military personnel records and scheduling VA examinations.

The Board remands the claims for service connection for type 2 diabetes and ischemic heart disease to obtain additional evidence regarding exposure to herbicides.

The Board granted service connection for ischemic heart disease, remanded the claims for hypertension and a left leg condition due to insufficient evidence.

The Board remands the appeal for a medical opinion to determine if the decedent's coronary artery disease and myocardial infarction are related to in-service chest pain.

The Board granted effective dates of August 31, 2015 for coronary artery disease and January 11, 2010 for diabetes mellitus and hypertension. A 70 percent disability rating was also granted for schizoaffective disorder, bipolar type, and a total disability rating based on individual unemployability (TDIU) due to service-connected disabilities.

The Board denied the veteran's claim for service connection for coronary artery disease, finding that there was no evidence of chronicity during service or within one year after discharge and no evidence linking the condition to an in-service injury or event.

The appeal for service connection for ischemic heart disease was dismissed as the claim for coronary artery disease and subacute or old myocardial infarction has been granted in full.

The Board denied service connection for skin cancer, congestive heart failure, coronary artery disease, hypertension, and bilateral lower extremity edema as the evidence did not support a finding that these conditions were incurred in or are otherwise etiologically related to the Veteran's active service.

The Board remands the claim for a rating in excess of 10 percent for coronary artery disease (CAD) with myocardial infarction to obtain an adequate VA examination and retrospective opinion.

The Board denied a disability rating greater than 10 percent for chondromalacia patellae in left knee with osteoarthritis and denied service connection for heart disorder, hypertension, and prostate disorder. However, the claim for tinnitus was granted, and readjudication of previously denied claims for bilateral hearing loss and right knee disorder were warranted.

The Board granted service connection for non-obstructive coronary artery disease (CAD) due to herbicide exposure during service, but denied a compensable rating for tinea pedis and service connection for a right foot condition.

The Board remands the matter to obtain an adequate medical opinion addressing the Veteran's service-connected psychiatric disorders and their relationship to his cause of death.

The Board granted an earlier effective date of May 3, 2024, for the increased rating of 100 percent for coronary artery disease (CAD), myocardial infarction, and special monthly compensation (SMC) at the 's' rate.

The Board remands the claims for a retrospective evaluation of coronary artery disease and TDIU due to conflicting medical evidence.

The Board remands the issues of entitlement to an increased rating for coronary artery disease and special monthly compensation for loss of use of right foot due to the need for additional evidence.

The Board denied the Veteran's claim for a higher disability rating for his service-connected ischemic heart disease, finding that the current 30 percent rating was appropriate. The skin condition issue was remanded for further development.